Shanghai Yingli Pharmaceutical Co., Ltd.
PrivateLast Round
Series A++
Mar 21, 2024
Total Funding Raised
$50M
Company Overview
Shanghai Yingli Pharmaceutical Co., Ltd. is a clinical-stage biotechnology company that researches and develops innovative oral small-molecule drugs for the treatment of oncology and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai Yingli Pharmaceutical Co., Ltd. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Shanghai Yingli Pharmaceutical Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A++ | Mar 21, 2024 | ||||
| Series A Extension | Nov 8, 2023 | ||||
| Strategic | Feb 8, 2021 | ||||
| Series A | Feb 2, 2021 |
Shanghai Yingli Pharmaceutical Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DYEE Capital | Series A Extension |
| 中南创投基金 | Series A |
| CICC Capital | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2023
Raised Series A Extension round with CICC Capital and DYEE Capital.
Shanghai Yingli Pharmaceutical Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Shanghai Yingli Pharmaceutical Co., Ltd.'s valuation, stock price, and market status.